SEARCH BY
Singleron develops and commercializes single-cell multi-omics products that can be used in both research and clinical settings. Singleron's current product portfolio includes instruments, microfluidic devices, reagents, software analysis, and database solutions that facilitate high-throughput single-cell analysis. The company currently has offices, laboratories, and manufacturing facilities in China, Germany, and the US. Its products are used in over 1,000 laboratories including hospitals, research institutes, and pharmaceutical companies. Singleron was founded in 2018 and is based in Jiangsu, China.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 1 |
| Sector: Life Science M&A | 1 of 1 |
| Type: Add-on Acquisition M&A Deals | 1 of 1 |
| Country: Singapore M&A | 1 of 1 |
| Year: 2022 M&A | 1 of 1 |